Dr. Blauvelt discusses the safety and efficacy of upadacitinib in patients with moderate-to-severe atopic dermatitis (AD). In terms of efficacy, he references the Heads Up
Dr. Chiesa Fuxench discusses the role of topical ruxolitinib for patients with mild-to-moderate atopic dermatitis, including those who have not responded adequately to topical corticosteroids
Andrew Mastro, MS, PA-C, outlines the proper clinical application of ruxolitinib cream 1.5% as a noncontinuous topical treatment for mild-to-moderate atopic dermatitis in nonimmunocompromised patients
Donna Lam Cahill, PA-C, outlines the psychosocial burdens of vitiligo, emphasizing that a patient’s disease burden does not always correlate directly with the amount of
Dr. Domingues discusses his tips for managing vitiligo as a chronic autoimmune disease, emphasizing patient engagement and setting realistic expectations for repigmentation. He reviews differences
Dr. Gooderham discusses using systemic Janus kinase (JAK) inhibitors like upadacitinib in patients with atopic dermatitis. She reviews appropriate indications for patient selection with JAK
Iltefat Hamzavi, MD, discusses the evolving role of Janus kinase (JAK) inhibition in the treatment of vitiligo. He compares JAK inhibitors such as topical ruxolitinib
Walter J. Liszewski, MD, an associate professor of dermatology at Northwestern University, discusses mechanisms of action to consider for treatment of patients with prurigo nodularis.
Harrison Nguyen, MD, MBA, MPH, FAAD, the managing director of Harrison Dermatology and Research Group and clinical assistant professor of dermatology at the University of
David Seiter, FNP-C, shares a patient success story involving a teenage patient with severe atopic dermatitis that achieved complete skin clearance within one week after
Leonardo Tjahjono, MD, FAAD, a clinical dermatologist at George Washington University in Washington, DC, discusses dosing regimens for spesolimab (Spevigo) every 4 weeks vs 12
Boni Elewski, MD, a professor and chair of dermatology at the University of Alabama in Birmingham, Alabama, discusses the characteristics and diagnosis of generalized pustular
Angela Lamb, MD, an associate professor of dermatology at the Icahn School of Medicine at Mount Sinai in New York, discusses recent advancements in understanding
David Rosmarin, MD, the chair of the Department of Dermatology at Indiana University in Indianapolis, discusses results from a pooled subgroup analysis of the 104-week
Ted Lain, MD, MBA, a board-certified dermatologist at Sanova Dermatology in Austin, Texas, discusses the randomized phase 3 THRIVE-AA1 trial (NCT04518995), which assessed the safety
Christopher Bunick, MD, PhD, an associate professor of dermatology at Yale School of Medicine in New Haven, Connecticut, discusses a poster presentation comparing the itch
Leon Kircik, MD, a board-certified dermatologist at the Icahn School of Medicine at Mount Sinai in New York, New York, discusses the history of isotretinoin
Dr. Cotter, a board-certified dermatologist at Las Vegas Dermatology, presents a real-world case of Prurigo Nodularis, highlighting both the severity of disease presentation and the
In our first installment of the new video series from the Physicians Council for Diversity, Equity, and Inclusion (PCDEI), an independent physician council, supported by
In our next installment of the video series from the Physicians Council for Diversity, Equity, and Inclusion (PCDEI), Dr. Ginn shares practical pearls for managing
In our first installment of the new video series from the Physicians Council for Diversity, Equity, and Inclusion (PCDEI), an independent physician council, supported by
Dr. Woolery-Lloyd discusses the safe and effective use of chemical peels in patients with skin of color, emphasizing a conservative approach to minimize the risk
Dr. Bunick explores the scientific principles guiding the next generation of small molecule therapies in dermatology. He outlines how intentional drug design can improve efficacy,
Dr. Bhutani discusses the unique presentation of inflammatory skin diseases in patients with skin of color, highlighting important diagnostic and treatment considerations for Psoriasis, Atopic
Dr. Dasilva examines longstanding laboratory monitoring practices in dermatology and encourages clinicians to reconsider routine testing as new evidence emerges. He reviews monitoring recommendations for
Dr. McMichael shares practical leadership insights for building and sustaining a successful dermatology department. She emphasizes creating a strong departmental culture in which every team
Dr. Mirmirani discusses hair loss during menopause, an often overlooked concern that can significantly affect women during the transition through midlife. She presents a 3-pillar
Dr. Elbuluk reviews practical strategies for evaluating and treating hyperpigmentation, hypopigmentation, and depigmentation in patients with skin of color. She emphasizes that accurate diagnosis and
Dr. Fallon-Friedlander discusses a case of an adolescent who presented with cognitive decline, forgetfulness, and seizures and was eventually diagnosed with subacute sclerosing panencephalitis.
Melissa Davis discusses a challenging case of a patient with neuritic leprosy.
Stephanie DePouw-Simmerman discusses her session that reviewed updates in treatment for patients with psoriasis.
Kirk Gautier assesses effective treatment options for patients with cutaneous diseases such as actinic keratosis, squamous cell carcinoma, and basal cell carcinoma.
Dr. Seiverling discusses the overlapping clinical features of atypical nevi and melanoma, as well as the diagnostic challenges this causes.
Dr. Abrar Qureshi emphasizes the importance of early diagnosis in hidradenitis suppurativa to improve pain management and drainage outcomes. Topics Covered: Early diagnosis of hidradenitis
Dr. Lio discusses the complex relationship between diet and atopic dermatitis, addressing common patient questions, misconceptions, and concerns regarding dietary modifications. His presentation emphasizes the
Dr. Graber reviews emerging evidence supporting the use of energy-based devices for the treatment of Acne Vulgaris and Rosacea, highlighting how advances in laser and
Dr. Daveluy discusses practical techniques and clinical considerations for using cryoinsufflation in the treatment of Hidradenitis Suppurativa (HS). His presentation provides guidance on incorporating this
Dr. Bunick examines the ongoing discussion surrounding benzene contamination concerns in benzoyl peroxide (BPO) products, addressing questions about product safety, regulatory oversight, and best practices
Dr. Lio discusses strategies for addressing chronic itch (pruritus) in patients undergoing treatment for non-dermatologic cancers, a symptom that can significantly affect comfort, sleep quality,
Dr. Daveluy explores the important relationship between nutrition and dermatologic therapies, discussing how dietary choices can influence the effectiveness, absorption, and side effect profiles of
Dr. Jennifer Hsiao shares emerging strategies for treating recalcitrant hidradenitis suppurativa when standard therapies fail. Topics Covered: Management of treatment-resistant HS Emerging therapies and clinical
Dr. Bunick provides a comprehensive review of the evolving role of antibiotics in treating Acne Vulgaris and Rosacea, examining current evidence on their benefits, limitations,
Dr. Swanson highlights key developments presented at the AAD 2025 Annual Meeting, providing an overview of emerging therapies, clinical research, and treatment advances across several
Drawing from his presentation at the AAD 2025 Annual Meeting, Dr. Rosmarin reviews practical strategies for maximizing treatment outcomes with Ruxolitinib> cream in patients with
Dr. Hamzavi reviews the role of surgical intervention in the management of Vitiligo, focusing on identifying appropriate candidates and outlining the available procedural techniques for
Dr. Hamzavi reviews key takeaways from his presentation during the AAD 2025 Annual Meeting session on surgical management of **Hidradenitis Suppurativa (HS). His discussion focuses
Dr. Chovatiya highlights key insights from a symposium presented at the AAD 2025 Annual Meeting, focusing on the diagnosis and management of **Chronic Hand Eczema
Drawing from his presentation at the AAD 2025 Annual Meeting, Dr. Drucker reviews findings from a network meta-analysis comparing systemic therapies for Atopic Dermatitis. His
In this recap of his presentation at the AAD 2025 Annual Meeting, Dr. Chovatiya examines the social and structural disparities that influence the diagnosis, treatment,
Dr. Gooderham reviews the evolving role of JAK inhibitors in the treatment of Psoriasis, focusing on how different mechanisms of JAK inhibition may influence therapeutic
Drawing from his presentation at the AAD 2025 Annual Meeting, Dr. Seneschal reviews the immune mechanisms underlying Vitiligo and explains why long-term maintenance therapy is
In the sixth installment of this series on skin glycation and aging, Dr. Draelos reviews patient-reported outcomes from a recently published clinical study evaluating the
Dr. Valacchi reviews histological findings from a study published in the March 2025 issue of Journal of Clinical and Aesthetic Dermatology that investigated the effects
Dr. Draelos reviews the methodology and findings of a clinical study published in the March 2025 issue of the Journal of Clinical and Aesthetic Dermatology,
In the third installment of The Science of Skin Glycation series, Drs. Draelos and Valacchi discuss emerging research on the potential role of rosemary extract
Drs. Watchmaker and Bucay explore how rosemary extract may help counter glycative stress and improve visible signs of skin aging from the inside out. Topics
In this first installment of a six-part series, Drs. Watchmaker and Bucay explore how glycative stress impacts skin health and aging. Their discussion focuses on
